Proposed Data Collection Submitted for Public Comment and Recommendations, 18460-18462 [2017-07880]
Download as PDF
<![CDATA[
18460
Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices
reduction in burden hours is attributed
primarily to the discontinuation of
previously approved forms and
formatting changes to existing forms.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Epidemiologist ...............
Epidemiologist ...............
NORS Foodborne Disease Transmission_Person to Person Disease Transmission_Animal
Contact_Environmental
Contamination_Unknown Transmission Mode_52.13.
WHO COLLABORATING CENTER FOR INFLUENZA Influenza Virus Surveillance.
U.S. WHO Collaborating Laboratories Influenza
Testing Methods Assessment.
U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Weekly_CDC 55.20.
U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Workfolder 55.20E.
Influenza-Associated Pediatric Mortality Case
Report Form.
Human Infection with Novel Influenza A Virus
Case Report Form.
Human Infection with Novel Influenza A Virus
Severe Outcomes.
Novel Influenza A Virus Case Screening Form ..
Antiviral Resistant Influenza Infection Case Report Form.
National Respiratory & Enteric Virus Surveillance System (NREVSS) (55.83A, B, D) (electronic).
National Enterovirus Surveillance Report: (CDC
55.9) (electronic).
National Adenovirus Type Reporting System
(NATRS).
Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form.
Viral Gastroenteritis Outbreak Submission Form
NORS Waterborne Disease Transmission
Form_52.12..
Influenza Virus (Electronic, Year Round),
PHLIP_HL7 messaging Data Elements.
Influenza virus (electronic, year round) (PHIN–
MS).
Suspect Respiratory Virus Patient Form .............
Total ........................
..............................................................................
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Number of
responses per
respondent
Number of
respondents
Type of respondent
37
20/60
666
53
52
10/60
460
113
1
10/60
19
1,800
52
10/60
15,600
1,800
1
5/60
150
57
2
30/60
57
57
2
30/60
57
57
1
1.5/60
86
57
57
1
3
15/60
30/60
15
86
550
52
15/60
7,150
20
12
15/60
60
13
4
15/60
13
57
3
25/60
72
20
57
5
1
5/60
20/60
9
19
57
52
5/60
247
3
52
5/60
13
10
5
30/60
25
........................
........................
........................
24,804
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–07902 Filed 4–18–17; 8:45 am]
[60Day–17–17ABC; Docket No. CDC–2017–
0033]
Centers for Disease Control and
Prevention
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
jstallworth on DSK7TPTVN1PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
SUMMARY:
VerDate Sep<11>2014
15:06 Apr 18, 2017
Jkt 241001
PO 00000
Frm 00045
Fmt 4703
Total burden
hours
54
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
BILLING CODE 4163–18–P
Average
burden
per response
(in hours)
Sfmt 4703
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled ‘‘Zika
Postpartum Emergency Response
Survey (ZPER), Puerto Rico, 2017.’’
DATES: Written comments must be
received on or before June 19, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0033 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
E:\FR\FM\19APN1.SGM
19APN1
jstallworth on DSK7TPTVN1PROD with NOTICES
Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
VerDate Sep<11>2014
15:06 Apr 18, 2017
Jkt 241001
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Zika Postpartum Emergency Response
Survey (ZPER), Puerto Rico, 2017—New
ICR—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In December 2015, the Puerto Rico
Department of Health (PRDH) reported
the first locally acquired (index) case of
Zika virus disease in the United States.
Since then, 38,733 cases have been
confirmed in Puerto Rico, including
3,076 among pregnant women. Because
the most common mosquito vector of
Zika virus, Aedes aegypti, is present
throughout Puerto Rico, Zika virus
transmission is ongoing. The island has
been designated at the highest level of
risk according to a 3-tiered Zika virus
infection risk scale developed by CDC’s
Emergency Operations Center (EOC).
While pregnant women do not differ
from the general population in terms of
susceptibility to Zika virus infection or
severity of disease, they are at risk for
adverse pregnancy and birth outcomes
associated with Zika virus infection
during pregnancy. After review of the
available evidence, CDC concluded that
Zika virus infection during pregnancy is
a cause of microcephaly and other brain
defects.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
18461
Given the adverse pregnancy and
birth outcomes associated with Zika
virus infection during pregnancy, it is
more important than ever to understand
the Zika-related concerns of pregnant
women, interactions regarding Zika
between pregnant women and their
health care providers, sources of
information that pregnant women
consult regarding Zika virus, and use of
recommended precautions by pregnant
women to reduce the risk of exposure to
Zika virus. This information was
successfully collected for the first time
in a hospital-based survey of women
24–48 hours after delivery by the Puerto
Rico Department of Health in the fall of
2016 (Emergency OMB approval,
control #0920–1127), and has been
critical for informing clinical guidance,
developing communication messages,
and providing resources for pregnant
women.
The currently proposed data
collection includes three components.
The first component is a telephone
follow-back survey among a subset of
the original cohort of participants. This
component would be the first
population-based sample of postpartum
women who were pregnant during the
early period of the Zika outbreak, and
would provide information on the
accessibility and utilization of
postpartum and newborn services, and
continued adherence to Zika prevention
behaviors. The second component
would repeat the hospital-based survey
in a second cohort of pregnant women
to assess the effectiveness of emergency
response efforts from the first mosquito
season and to determine where there is
a need for further refinement of efforts
and outstanding resource gaps. As with
the first cohort of women who
participated in hospital-based survey, a
subset of women in this second cohort
would be invited to subsequently
participate in a telephone follow-up
survey. The third and final component
will be a separate hospital-based survey
for fathers of the infants born to mothers
in the second cohort of women
completing the hospital-based survey.
This component would assess father’s
concerns about Zika related birth
defects and contribution to prevention
efforts.
There are no costs to respondents
other than their time to participate.
E:\FR\FM\19APN1.SGM
19APN1
18462
Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hrs.)
Total burden
(in hrs.)
Type of respondents
Form name
Women with recent births .................
Maternal hospital-based questionnaire.
Father hospital-based questionnaire
Follow-up phone questionnaire ........
2,760
1
25/60
1,150
1,104
2,868
1
1
15/60
15/60
276
717
...........................................................
........................
........................
........................
2,143
Fathers with recently born infants ....
Women with live births 2–10 months
prior.
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–07880 Filed 4–18–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Prevention, 1600 Clifton Road, NE.,
MS–D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Centers for Disease Control and
Prevention
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
[60Day–17–17NF; Docket No. CDC–2017–
0006]
FOR FURTHER INFORMATION CONTACT:
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled ‘‘ZIRP Puerto
Rico Study: Zika Virus RNA Persistence
in Pregnant Women and CongenitallyInfected Infants in Puerto Rico.’’
DATES: Written comments must be
received on or before June 19, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0006 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
jstallworth on DSK7TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:06 Apr 18, 2017
Jkt 241001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
ZIRP Puerto Rico Study: Zika Virus
RNA Persistence in Pregnant Women
and Congenitally-Infected Infants in
Puerto Rico—New—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Zika virus (ZIKV) infection is a
mosquito-borne flavivirus transmitted
by Aedes species mosquitoes, and also
through sexual and mother-to-child
transmission; laboratory-acquired
infections have also been reported.
Evidence of human ZIKV infection was
observed sporadically in Africa and
Asia prior to 2007 when an outbreak of
ZIKV caused an estimated 5,000
infections in the State of Yap, Federated
States of Micronesia.
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 82, Number 74 (Wednesday, April 19, 2017)]
[Notices]
[Pages 18460-18462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07880]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-17-17ABC; Docket No. CDC-2017-0033]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Zika Postpartum Emergency
Response Survey (ZPER), Puerto Rico, 2017.''
DATES: Written comments must be received on or before June 19, 2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0033 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office,
[[Page 18461]]
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Zika Postpartum Emergency Response Survey (ZPER), Puerto Rico,
2017--New ICR--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
In December 2015, the Puerto Rico Department of Health (PRDH)
reported the first locally acquired (index) case of Zika virus disease
in the United States. Since then, 38,733 cases have been confirmed in
Puerto Rico, including 3,076 among pregnant women. Because the most
common mosquito vector of Zika virus, Aedes aegypti, is present
throughout Puerto Rico, Zika virus transmission is ongoing. The island
has been designated at the highest level of risk according to a 3-
tiered Zika virus infection risk scale developed by CDC's Emergency
Operations Center (EOC).
While pregnant women do not differ from the general population in
terms of susceptibility to Zika virus infection or severity of disease,
they are at risk for adverse pregnancy and birth outcomes associated
with Zika virus infection during pregnancy. After review of the
available evidence, CDC concluded that Zika virus infection during
pregnancy is a cause of microcephaly and other brain defects.
Given the adverse pregnancy and birth outcomes associated with Zika
virus infection during pregnancy, it is more important than ever to
understand the Zika-related concerns of pregnant women, interactions
regarding Zika between pregnant women and their health care providers,
sources of information that pregnant women consult regarding Zika
virus, and use of recommended precautions by pregnant women to reduce
the risk of exposure to Zika virus. This information was successfully
collected for the first time in a hospital-based survey of women 24-48
hours after delivery by the Puerto Rico Department of Health in the
fall of 2016 (Emergency OMB approval, control #0920-1127), and has been
critical for informing clinical guidance, developing communication
messages, and providing resources for pregnant women.
The currently proposed data collection includes three components.
The first component is a telephone follow-back survey among a subset of
the original cohort of participants. This component would be the first
population-based sample of postpartum women who were pregnant during
the early period of the Zika outbreak, and would provide information on
the accessibility and utilization of postpartum and newborn services,
and continued adherence to Zika prevention behaviors. The second
component would repeat the hospital-based survey in a second cohort of
pregnant women to assess the effectiveness of emergency response
efforts from the first mosquito season and to determine where there is
a need for further refinement of efforts and outstanding resource gaps.
As with the first cohort of women who participated in hospital-based
survey, a subset of women in this second cohort would be invited to
subsequently participate in a telephone follow-up survey. The third and
final component will be a separate hospital-based survey for fathers of
the infants born to mothers in the second cohort of women completing
the hospital-based survey. This component would assess father's
concerns about Zika related birth defects and contribution to
prevention efforts.
There are no costs to respondents other than their time to
participate.
[[Page 18462]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Women with recent births...... Maternal 2,760 1 25/60 1,150
hospital-based
questionnaire.
Fathers with recently born Father hospital- 1,104 1 15/60 276
infants. based
questionnaire.
Women with live births 2-10 Follow-up phone 2,868 1 15/60 717
months prior. questionnaire.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 2,143
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-07880 Filed 4-18-17; 8:45 am]
BILLING CODE 4163-18-P
